Open access
Sep 2026
Targeting UAP1 with rabeprazole: a novel repurposed therapeutic strategy for multiple myeloma
Despite significant advancements in proteasome inhibitors and immunomodulatory drugs, multiple myeloma (MM) remains largely incurable due to persistent drug resistance and frequent relapse, highlighting an urgent need for novel therapeutic targets. We analyzed Multiple Myeloma Research Foundation and GEO d...
Long-Hao Cheng, Hu Cheng, Bing Hu et al.
· Frontiers in Pharmacology · 0 citations